We are live on ! Find out more
HRTX icon

Heron Therapeutics
HRTX

102 hedge funds and large institutions have $1.06B invested in Heron Therapeutics in 2015 Q3 according to their latest regulatory filings, with 28 funds opening new positions, 43 increasing their positions, 19 reducing their positions, and 13 closing their positions.

New
Increased
Maintained
Reduced
Closed

202% more call options, than puts

Call options by funds: $127M | Put options by funds: $41.9M

126% more repeat investments, than reductions

Existing positions increased: 43 | Existing positions reduced: 19

115% more first-time investments, than exits

New positions opened: 28 | Existing positions closed: 13

16% more funds holding

Funds holding: 88 → 102 (+14)

0% more funds holding in top 10

Funds holding in top 10: 4 → 4 (0)

5% less capital invested

Capital invested by funds: $1.13B → $1.06B (-$61M)

Holders
102
Holders Change
+14
Holders Change %
+15.91%
% of All Funds
2.85%
Holding in Top 10
4
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.11%
New
28
Increased
43
Reduced
19
Closed
13
Calls
$127M
Puts
$41.9M
Net Calls
+$84.8M
Net Calls Change
+$4.85M

Top Buyers

1
Fidelity Investments
Fidelity Investments
Massachusetts
+$119M
2
Invesco
Invesco
Georgia
+$75.6M
3
JHIU
Janus Henderson Investors US
Colorado
+$40.9M
4
PHS
PFM Health Sciences
California
+$38.4M
5
Goldman Sachs
Goldman Sachs
New York
+$24M

Top Sellers

1
Millennium Management
Millennium Management
New York
-$23.7M
2
BC
Broadfin Capital
New York
-$17.8M
3
Franklin Resources
Franklin Resources
California
-$17.4M
4
Susquehanna International Group
Susquehanna International Group
Pennsylvania
-$15.5M
5
PA
Perceptive Advisors
New York
-$14M
Name Holding Trade Value Shares
Change 		Change in
Stake
GC
51
Guggenheim Capital
Illinois
$1.18M +$1.61M +48,372 New
EI
52
EAM Investors
California
$1.02M -$318K -9,540 -19%
RFC
53
Russell Frank Company
Washington
$811K -$21.3K -639 -2%
GH
54
GAM Holding
Switzerland
$793K +$1.08M +32,500 New
New York State Common Retirement Fund
55
New York State Common Retirement Fund
New York
$676K +$99K +2,970 +12%
Tudor Investment Corp
56
Tudor Investment Corp
Connecticut
$647K +$252K +7,561 +40%
SO
57
STRS Ohio
Ohio
$644K – – –
RhumbLine Advisers
58
RhumbLine Advisers
Massachusetts
$642K +$158K +4,734 +22%
HighTower Advisors
59
HighTower Advisors
Illinois
$627K +$548K +16,443 +177%
PPA
60
Parametric Portfolio Associates
Washington
$619K +$529K +15,865 +167%
NI
61
Numeric Investors
Massachusetts
$561K +$766K +23,000 New
Wells Fargo
62
Wells Fargo
California
$528K +$478K +14,354 +197%
MLICM
63
Metropolitan Life Insurance Company (MetLife)
New York
$506K +$121K +3,630 +21%
BA
64
BlackRock Advisors
Delaware
$458K +$85K +2,550 +16%
NFA
65
Nationwide Fund Advisors
Ohio
$456K +$90.2K +2,708 +17%
Simplex Trading
66
Simplex Trading
Illinois
$455K +$552K +16,552 +788%
SIM
67
Spark Investment Management
New York
$427K – – –
BG
68
BlackRock Group
United Kingdom
$366K +$500K +15,000 New
AL
69
Airain Ltd
Guernsey
$355K +$484K +14,536 New
AIG
70
American International Group
New York
$353K +$567 +17 +0.1%
LP
71
LMR Partners
United Kingdom
$326K +$445K +13,363 New
VOYA Investment Management
72
VOYA Investment Management
Georgia
$322K – – –
State Board of Administration of Florida Retirement System
73
State Board of Administration of Florida Retirement System
Florida
$282K +$56.3K +1,690 +17%
SEI Investments
74
SEI Investments
Pennsylvania
$280K +$383K +11,483 New
BFM
75
Boothbay Fund Management
New York
$265K +$362K +10,854 New
1 2
3
4 5

HRTX Hedge Fund Activity: Q3 2015 in Review

102 of the 3,582 institutional investors tracked by Wall St. Rank reported a position in Heron Therapeutics (HRTX) for Q3 2015, worth a combined $1.06B — down 5.4% from $1.13B a quarter earlier.

Buyers outnumbered sellers: 28 funds opened new HRTX positions and 13 closed out — a net gain of 15 holders — while 43 added to existing stakes and 19 trimmed.

The largest buyer was Fidelity Investments, adding an estimated $119M. The largest seller was Millennium Management, exiting entirely with an estimated $23.7M sold.

  • 102 institutional investors held Heron Therapeutics (HRTX) as of Q3 2015, up from 88 in Q2 2015.
  • Funds reported $1.06B of Heron Therapeutics stock for Q3 2015, down 5.4% quarter-over-quarter.
  • 28 funds opened new Heron Therapeutics positions in Q3 2015 and 13 closed out, a net change of +15 holders.
  • The largest Heron Therapeutics buyer in Q3 2015 was Fidelity Investments, an estimated $119M added.
  • The largest Heron Therapeutics seller in Q3 2015 was Millennium Management, an estimated $23.7M sold.

Based on aggregated 13F filings for Q3 2015.